²é¿´: 1281  |  »Ø¸´: 6
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

wpl581

ľ³æ (ÕýʽдÊÖ)


[½»Á÷] ³æÓÑÃÇ£¬¿´¿´PLos oneµÄÕâ¸öÉó¸åÒâ¼ûÊÇʲôÒâ˼£¬ÇóÖ¸½Ì£¡Ð»Ð»

ÎÒ×öµÄÒ»¸ö»¯ºÏÎïµÄÒ©Îï´úл£¬·ÖÎö·½·¨£ºÅäÖÃһϵÁÐŨ¶ÈµÄQC´¢±¸Òº£¬È¡100ul¿Õ°×Ѫ½¬£¬·Ö±ð¼ÓÈë10ulµÄQC´¢±¸ÒººÍ5ulµÄÄڱ꣬ÎÐÐý»ìÔȺó£¬ÝÍÈ¡£¬ÀëÐÄ£¬ÉÏÇåÒº´µ¸É£¬È¡100ul¼×´¼¸´ÈÜ£¬ÀëÐÄ£¬È¡10ul½øÑù£¬ºÃ¶àÎÄÏ×¶¼ÊÇÕâô×öµÄѽ£¡
ΪʲôÉó¸åÈ˸øÁËÈçϵÄÒâ¼û£ºas regard the analytical method, the preparation of standards and quality controls£¨QC£© is done using too much organic solution (>10%) compared to the matrix. FDA highly recommends the use of solvent in a percentage not exceeding 5% the volume of the matrix.
Çó½â£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wpl581

ľ³æ (ÕýʽдÊÖ)


ÒýÓûØÌû:
2Â¥: Originally posted by m_marion at 2012-12-28 19:22:48
È˼ÒÉó¸åÈËÌá³öµÄÒªÇóÊÇFDA±ê×¼£¬Äã¿´µÄÎÄÏ×ÊÇʲô¹ú¼ÒµÄÔÓÖ¾£¿°´Ê²Ã´±ê×¼£¿

²Î¿¼µÄEur J Drug Metab Pharmacokinet (2011)ÉϵÄһƪÎÄÏ×£¬²ÉÓõÄÀàËÆ·½·¨
3Â¥2012-12-28 19:37:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ wpl581 µÄÖ÷Ìâ¸üÐÂ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û